文献速递免疫规划传染病防控与疫情报告

德国2020年接种佐剂重组带状疱疹疫苗后皮肤表现的调查

Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020.
PubMed 文献 · Euro Surveill · 2023-01-01

2020年4月至10月,德国国家主管机构保罗-埃利希研究所邀请报告接种佐剂重组带状疱疹疫苗(RZV)后疑似带状疱疹或带状疱疹样皮肤表现的全科医生参与研究。共纳入72例分析,27份样本经PCR检测水痘-带状疱疹病毒(VZV)阳性且均为野生型,3份为HSV-1阳性,5份为HSV-2阳性。结论认为无PCR结果时难以区分带状疱疹与其他带状疱疹样表现。

要点

  • 接种RZV后出现的皮节性皮疹中,27份样本VZV-PCR阳性且均为野生型。
  • 72例中45例为女性,33例年龄60-69岁,32例皮损位于胸部皮节,27例位于颈部皮节。
  • 无PCR结果时,难以将带状疱疹与其他带状疱疹样表现区分开。

核心结论

  • 无PCR结果时可能难以将带状疱疹与其他带状疱疹样表现区分开。
  • 本研究中接种RZV后最初几周内出现的VZV-PCR阳性皮节性皮疹由野生型VZV引起,这并不意外,因为带状疱疹是常见疾病,疫苗此时不太可能提供完全保护。

研究设计与样本

  • 2020年4月至10月,德国全科医生向保罗-埃利希研究所报告接种RZV后疑似带状疱疹或带状疱疹样皮肤表现,受邀参与研究。
  • 全科医生采集皮肤表现样本、拍照并收集患者RZV接种及疑似不良事件信息。
  • 所有样本经PCR检测VZV和单纯疱疹病毒(HSV),VZV阳性样本进行基因分型,病例由两名皮肤科医生独立评估。

主要发现

  • 72例中45例为女性,33例年龄60-69岁,32例皮肤症状位于胸部皮节,27例位于颈部皮节。
  • 27份样本VZV-PCR阳性(均基因分型为野生型),3份HSV-1阳性,5份HSV-2阳性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundShortly after the launch of a novel adjuvanted recombinant zoster vaccine (RZV), Shingrix, cases of suspected herpes zoster (HZ) or zoster-like skin reactions following immunisation were reported.AimWe aimed to investigate if these skin manifestations after administration of RZV could be HZ.MethodsBetween April and October 2020, general practitioners (GP) reporting a suspected case of HZ or zoster-like skin manifestation after RZV vaccination to the Paul-Ehrlich-Institut, the German national competent authority, were invited to participate in the study. The GP took a sample of the skin manifestation, photographed it and collected patient information on RZV vaccination and the suspected adverse event. We analysed all samples by PCR for varicella-zoster virus (VZV) and herpes-simplex virus (HSV) and genotyped VZV-positive samples. In addition, cases were independently assessed by two dermatologists.ResultsEighty eligible cases were enrolled and 72 could be included in the analysis. Of the 72 cases, 45 were female, 33 were 60-69 years old, 32 had skin symptoms in the thoracic and 27 in the cervical dermatomes. Twenty-seven samples tested PCR positive for VZV (all genotyped as wild-type, WT), three for HSV-1 and five for HSV-2.ConclusionIt may be difficult to distinguish HZ, without a PCR result, from other zoster-like manifestations. In this study, VZV-PCR positive dermatomal eruptions occurring in the first weeks after immunisation with RZV were due to WT VZV, which is not unexpected as HZ is a common disease against which the vaccine is unlikely to provide full protection at this time.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Orru' S, Bierbaum S, Enk A, et al. Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020. Euro Surveill. 2023. PMID: 38099347. doi:10.2807/1560-7917.ES.2023.28.50.2300261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。